EUVIMEDEUVIMED entdecken
Crossref

MBene nanozyme orchestrates antibacterial and osteoimmune responses for synergistic therapy of methicillin-resistant Staphylococcus aureus-infected osteomyelitis

Yang Yu, Xiumeng Zhang, Xiaojun He, Ying Chen

Acta Biomaterialia · 2026-06 · 217 · 713-725

DOI: 10.1016/j.actbio.2026.05.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-06. Verfasst von Yang Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China; Departments of Orthopaedics, The …. Hauptthemen laut MEDLINE: Osteomyelitis, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The deep-seated location of methicillin-resistant Staphylococcus aureus (MRSA)-induced osteomyelitis within the host, combined with insufficient antibiotic penetration into bone and the capacity of MRSA to form biofilms, may render conventional therapies ineffective. A promising alternative is chemodynamic therapy (CDT), which locally generates cytotoxic hydroxyl radicals. However, the efficacy of such agents as monotherapy is significantly compromised by the hypoxic microenvironment characteristic of deep-seated bone infections. This study introduces a copper-doped molybdenum boride (Cu@MoB) nanozyme, which exhibits impressive photothermal conversion and multi-enzyme mimetic activities (oxidase and peroxidase), thereby enabling effective cooperative photothermal therapy (PTT) and CDT. In a mouse model of MRSA osteomyelitis, the PTT/CDT mediated by Cu@MoB successfully eradicated bacteria from the intramedullary space and enhanced the repair of the infected bone. Furthermore, it exhibited superior efficacy in vivo compared to vancomycin, the gold standard antibiotic currently employed in clinical practice. An increase in TGF-β levels in the bone marrow associated with inflammation was observed following treatment, indicating that the inhibition of the inflammatory microenvironment contributed to the effectiveness of treatment. Further transcriptomic sequencing analyses revealed that Cu@MoB downregulated the expression of pro-inflammatory genes, including Il1b, Il6, Tnf, and Ccl2, while inhibiting several inflammatory pathways, such as the Toll-like receptor, NF-κB, and Th17 pathways. Cu@MoB has the potential to serve as a MBene-based nanoplatform for the synergistic treatment of drug-resistant, deep-seated infections, representing a strategy for anti-infective bone defect repair. STATEMENT OF SIGNIFICANCE: The treatment of MRSA-induced osteomyelitis remains challenging due to the presence of deep-seated infection foci, biofilm formation, and limited antibiotic penetration. We developed a copper-doped MBene nanozyme (Cu@MoB) that integrates photothermal therapy and chemodynamic therapy into a single platform for synergistic antibacterial treatment. Unlike conventional approaches, our rationally designed Cu@MoB leverages copper doping to simultaneously enhance Fenton-like catalytic activity under near-physiological pH while maintaining excellent photothermal conversion efficiency. This work demonstrates, for the first time, that Cu@MoB-mediated PTT/CDT synergy not only eradicates intramedullary MRSA more effectively than vancomycin but also modulates the osteoimmune microenvironment by downregulating pro-inflammatory pathways (TLR, NF-κB, Th17) to promote bone regeneration. This approach offers a paradigm-shifting strategy for treating drug-resistant deep-seated infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsStaphylococcal InfectionsMolybdenumNanoparticlesAnimalsMiceCopperPhotothermal Therapy

Stichwörter der Autor:innen

Anti-infective therapyMBeneMRSANanozymesOsteomyelitis

Substanzen

Anti-Bacterial AgentsMolybdenumCopper

Autor:innen und Institutionen

  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China; Departments of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou M…
  • Department of Ophthalmology, Peking University First Hospital, Beijing 100034, China. Electronic address: 21394@pkufh.com.
  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China; Departments of General Practice, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzh…

Förderung

  • National Natural Science Foundation of China
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Yu, Y., Zhang, X., He, X., & Chen, Y. (2026). MBene nanozyme orchestrates antibacterial and osteoimmune responses for synergistic therapy of methicillin-resistant Staphylococcus aureus-infected osteomyelitis. Acta Biomaterialia, 217, 713-725. https://doi.org/10.1016/j.actbio.2026.05.027

Vancouver

Yu Y, Zhang X, He X, Chen Y. MBene nanozyme orchestrates antibacterial and osteoimmune responses for synergistic therapy of methicillin-resistant Staphylococcus aureus-infected osteomyelitis. Acta Biomaterialia. 2026;217:713-725. doi:10.1016/j.actbio.2026.05.027

BibTeX
@article{Yu2026,
  author = {Yu, Yang and Zhang, Xiumeng and He, Xiaojun and Chen, Ying},
  title = {MBene nanozyme orchestrates antibacterial and osteoimmune responses for synergistic therapy of methicillin-resistant Staphylococcus aureus-infected osteomyelitis},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {217},
  pages = {713--725},
  doi = {10.1016/j.actbio.2026.05.027}
}
Kostenlos starten →